Our Chief Business Officer, John Truesdell, will be presenting at Fierce Biotech Week, which will feature insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.
To schedule a meeting with the Company while in attendance, please contact InvestorRelations@foresight-dx.com or BD@foresight-dx.com